Using our extensive experience in providing accelerated ISO13485 Accredited design, development, manufacture and distribution of in vitro diagnostics, Medtechtomarket are proud to be helping mitigate the impact of coronavirus and developing rapid diagnostic solutions to fight this pandemic.
Entegrion’s point-of-care VCM Cascade system for measuring patient haemostasis that was developed, CE marked and still manufactured by Medtechtomarket is being successfully used by a number of the world’s leading authorities in ICU medicine for the therapy monitoring of Covid-19 critically ill patients, as reported in the 31st Annual Elso Conference (Mauro Panigada et al., Sept 2020). The system performs better than the current gold standard coagulation test in monitoring the stability and dosing of heparinised patients, and we look forward to hearing more about this ground breaking medicine.
Medtechtomarket have been working with a local not-for-profit organisation with regulatory and technical support for the production of single-use visors, in our national effort to produce PPE aimed at protecting the frontline NHS staff during the COVID-19 outbreak.
One of our portable near-patient diagnostic systems that we developed and continue to manufacture is currently being used in emergency clinical trials across multi-centre intensive care units to provide hard data for COVID-19 patient triaging, guiding their therapy, and monitoring stability.